Keynote Speakers
OverviewSELECTBIO is thrilled to announce the continuation of Stem Cells in Drug Discovery for 2017. Owing to the success of the meeting in 2015 and 2016, this will be a larger, multi-track event being held alongside Antibodies in Drug Discovery, Epigenetics in Drug Discovery and Academic Drug Discovery. Taking place at the Wellcome Genome Campus Conference Centre in Cambridge, UK on 6 - 7 March 2017, attendees will benefit from unrestricted access to all four tracks. Progress in developmental and stem cell biology is revolutionising drug discovery research; the ability to grow and differentiate stem cell lines is providing a far more relevant model for pre-clinical testing. So much so that the FDA is looking into replacing previous models as a matter of urgency. However, challenges in assay development, scale up and quality control still persist and need to be addressed in order for success in this field to continue. Stem Cells in Drug Discovery 2017 will see an even larger event with more talks, attendees and discussions than ever before. Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies enabling them to do so. There will also be discussions on industry and regulatory developments that are shaping the future of drug discovery. Registration includes unrestricted access to all conference tracks and a reception dinner at the end of the first day. SELECTBIO is offering a limited number of student bursaries at this event. Find out more
|
.gif){kind=logo}
.gif)
